Carolyn Carden - 25 Apr 2022 Form 3 Insider Report for PETMED EXPRESS INC (PETS)

Reporting relationship: VP of Product
Issuer ticker: PETS
Reported as of: 25 Apr 2022
Net transaction value: $0
SEC form: 3
Accepted by SEC: 17 May 2022, 09:26:06 UTC
Source filing: View source filing
Reporting owner signature: /s/ Carolyn Carden

Key filing fact

Carolyn Carden filed Form 3 for PETMED EXPRESS INC (PETS) on 17 May 2022.

Key facts

This page summarizes Carolyn Carden's Form 3 filing for PETMED EXPRESS INC (PETS).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 17 May 2022, 09:26.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PETS holding

COMMON STOCK

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,000
Date: 25 Apr 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 6,000 shares of restricted stock ("RSU") under the Company's 2016 Employee Equity Compensation Restricted Stock Plan (the "2016 Plan"), which stock restrictions will lapse pro rata on each of April 25, 2023, April 25, 2024 and April 25, 2025, which are subject to forfeiture in the event of termination of employment (except as provided in the RSU agreement). Ms.Carden retains voting rights over all the shares subject to forfeiture while in escrow.